CTORCITIUS ONCOLOGY, INC.vs its industry peers
A metric-by-metric comparison of CITIUS ONCOLOGY, INC. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTORThis | $89M#9 | — | 2.2x#3 | — | — | -17.1%#12 | — | -61.3%#6 | — | — | -48.3%#3 | — |
| PMN | $112M#1 | — | 2.3x#5 | — | — | -1529.3%#16 | — | -80.4%#8 | — | — | — | — |
| MIST | $111M#2 | — | 6.1x#9 | — | — | -51.9%#14 | — | -0.3%#2 | — | — | — | — |
| GNLX | $107M#3 | — | 6.6x#11 | 13347.4x#6 | 0.0%#5 | -7.6%#10 | -415175.0%#7 | -199.5%#13 | -424.2%#2 | — | — | — |
| COYA | $106M#4 | — | 2.4x#6 | 13.3x#3 | 123.6%#1 | -42.6%#13 | -283.9%#4 | -49.0%#5 | — | — | — | — |
| CPIX | $104M#5 | — | 6.0x#8 | 2.3x#1 | 17.6%#3 | 56.2%#4 | -6.3%#2 | -16.3%#4 | — | — | — | — |
| PLYX | $101M#6 | — | 9.3x#12 | — | — | 70.4%#3 | — | -82.1%#9 | — | — | — | — |
| RLYB | $89M#8 | 3.4x#2 | 0.9x#2 | 104.0x#4 | 34.9%#2 | 84.5%#1 | -3853.6%#5 | -9.5%#3 | — | — | — | — |
| ANIX | $91M#7 | — | 6.3x#10 | 431.2x#5 | 0.0%#5 | 13.0%#7 | -5571.9%#6 | -75.5%#7 | -87.0%#1 | — | -27.2%#1 | — |
| EMMA | $84M#10 | — | — | 6.8x#2 | -25.2%#7 | -16.1%#11 | 1.9%#1 | — | — | 4#1 | — | — |
| MAIA | $84M#11 | — | 4.1x#7 | — | — | 3.7%#8 | — | -108.3%#12 | — | — | — | — |
| ALDX | $84M#12 | — | 2.2x#4 | — | — | 39.4%#5 | — | -89.3%#10 | — | — | -71.9%#4 | — |
| ACET | $84M#13 | — | 0.7x#1 | — | — | 0.3%#9 | — | -97.2%#11 | — | — | — | — |
| FBIO | — | 0.9x#1 | — | — | 9.7%#4 | 76.2%#2 | -111.0%#3 | 22.5%#1 | — | — | -27.9%#2 | — |
| OSTX | $80M#14 | — | — | — | — | -223.7%#15 | — | — | — | — | — | — |
| TELO | $80M#15 | — | 15.8x#13 | — | — | 37.0%#6 | — | -206.9%#14 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice